Endurant Capital Management’s Takeda Pharmaceutical TAK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-1,102,280
| Closed | -$14.3M | – | 71 |
|
|
2022
Q3 | $14.3M | Buy |
+1,102,280
| New | +$14.3M | 4.66% | 4 |
|
|
2020
Q2 | – | Sell |
-156,120
| Closed | -$2.37M | – | 72 |
|
|
2020
Q1 | $2.37M | Buy |
+156,120
| New | +$2.37M | 1.07% | 26 |
|
|
2019
Q4 | – | Sell |
-92,273
| Closed | -$1.59M | – | 65 |
|
|
2019
Q3 | $1.59M | Sell |
92,273
-840,694
| -90% | -$14.5M | 0.57% | 30 |
|
|
2019
Q2 | $16.5M | Buy |
932,967
+495,531
| +113% | +$8.77M | 6.51% | 1 |
|
|
2019
Q1 | $8.91M | Buy |
+437,436
| New | +$8.91M | 3.52% | 8 |
|